A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
Clinical trial NCT05234736 · COMPLETED
Trial details
- NCT number
- NCT05234736
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2022-06-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.